SCVC

SCVC is a Bristol-based early-stage venture capital firm that focuses on deep tech startups. It was co-founded in 2020 by Dr. Harry Destecroix and Jon Craton, both successful entrepreneurs with backgrounds in biotech and technology. SCVC is the venture arm of the Science Creates ecosystem, which supports innovative tech startups emerging from research institutions. The firm primarily invests in pre-seed and seed-stage startups, with typical investment sizes ranging from $500,000 to $3 million, and follow-on funding of up to $7 million for high-performing companies. SCVC is particularly focused on advanced technologies that improve human health and the environment, including biotech, quantum tech, AI, and semiconductors. Notable portfolio companies include VyperCore, a RISC-V processor company, Delta g, which develops quantum gravity sensors, and Scarlet Therapeutics, which pioneers red blood cell-based therapies. SCVC's mission is to support deep tech founders by offering not just capital but also hands-on expertise to turn their scientific breakthroughs into commercial ventures. With its second fund targeting $100 million, SCVC is expanding its efforts to back high-impact startups that are leading what they believe to be the next major industrial revolution​.